BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26080809)

  • 1. Polymer-Drug Conjugates for Anticancer Drug Delivery.
    Wadhwa S; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):215-45. PubMed ID: 26080809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery.
    Kaur H; Desai SD; Kumar V; Rathi P; Singh J
    Anticancer Agents Med Chem; 2016; 16(11):1355-1377. PubMed ID: 27141881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment.
    Gupta C; Naik I; Menon M; Ambre P; Coutinho E
    Curr Drug Deliv; 2022; 20(1):8-30. PubMed ID: 35400344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy.
    Theodosis-Nobelos P; Charalambous D; Triantis C; Rikkou-Kalourkoti M
    Curr Drug Deliv; 2020; 17(7):542-557. PubMed ID: 32384029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
    Sun H; Yarovoy I; Capeling M; Cheng C
    Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in polymer-drug conjugated micelles in the delivery of anticancer drugs].
    Yin XL; Zhang B; Liu YJ; Zhang N
    Yao Xue Xue Bao; 2016 May; 51(5):710-6. PubMed ID: 29874007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting EPR in polymer drug conjugate delivery for tumor targeting.
    Modi S; Prakash Jain J; Domb AJ; Kumar N
    Curr Pharm Des; 2006; 12(36):4785-96. PubMed ID: 17168778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart linkers in polymer-drug conjugates for tumor-targeted delivery.
    Chang M; Zhang F; Wei T; Zuo T; Guan Y; Lin G; Shao W
    J Drug Target; 2016; 24(6):475-91. PubMed ID: 26560242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable polymers for targeted delivery of anti-cancer drugs.
    Doppalapudi S; Jain A; Domb AJ; Khan W
    Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
    Chytil P; Koziolová E; Etrych T; Ulbrich K
    Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28805040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
    Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
    J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics.
    Wang Y; Xia H; Chen B; Wang Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1828. PubMed ID: 35734967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-targeted polymeric drugs.
    Luo Y; Prestwich GD
    Curr Cancer Drug Targets; 2002 Sep; 2(3):209-26. PubMed ID: 12188908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive micelles self-assembled from polymer brush (PAE-
    Huang X; Liao W; Zhang G; Kang S; Zhang CY
    Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-Based Drug Delivery Systems for Cancer.
    Wen R; Umeano AC; Chen P; Farooqi AA
    Crit Rev Ther Drug Carrier Syst; 2018; 35(6):521-553. PubMed ID: 30317968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.